Completed OBSERVATIONAL NCT00723567

A Novel Mutation of the Spectrin Gene

Case Report: A Novel Mutation of the Spectrin Gene in a Family of Northern European Descent Is Associated With Three Different Phenotypes

Sponsor: University of Utah

Conditions Hereditary Elliptocytosis (HE) Hereditary Pyropoikilocytosis (HPP)

Updated 6 times since 2017 Last updated: Feb 18, 2009 Started: Feb 29, 2008 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hereditary Elliptocytosis (HE) and Hereditary Pyropoikilocytosis (HPP) and is currently completed. University of Utah leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Utah
University of Witwatersrand, South Africa

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States